Publication | Open Access
A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)
22
Citations
4
References
2020
Year
Chinese Clinical Trial Registry: ChiCTR2000028777 (registered on January 3, 2020).
| Year | Citations | |
|---|---|---|
Page 1
Page 1